| ¿µ¹® | urokinase | ÇÑ±Û | ¿ì·ÎŰ³ª¾ÆÁ¦ |
|---|---|---|---|
| ¼³¸í | »ç¶÷ µîÀÇ Æ÷À¯µ¿¹°À̳ª ±âŸ ôÃßµ¿¹°ÀÇ ¿äÁß¿¡ Á¸ÀçÇÏ´Â È¿¼Ò·Î¼, »ç¶÷ÀÇ ÄáÆÏ ½ÇÁú¼¼Æ÷¿¡ ÀÇÇÏ¿© Çü¼ºµÇ¸ç Çö󽺹̳ë°Õ Ȱ¼ºÃ¼·Î¼ ÀÛ¿ëÇÑ´Ù. »ç¶÷À̳ª µ¿¹°ÀÇ ÇÇ¿Í ¿ÀÁÜ¿¡ ÀÖ°í, Ç÷Àü¿ëÇØ¼º ȤÀº ¼¶À¯¼Ò¿ëÇØ¼º¹°Áú·Î »ç¿ëµÈ´Ù. |
||
| PLAUR | plasminogen activator receptor, urokinase type |
|---|---|
| SCU-PA | single-chain urokinase plasminogen activator |
| SUMIT | streptokinase-urokinase myocardial infarct test |
| UPET | urokinase pulmonary embolism trial |
| URK | urokinase |
| Pro-UK | Pro-Urokinase |
|---|---|
| rscu-PA | Recombinant single-chain urokinase-type plasminogen activator |
| scu-PA | Single-chain urokinase-type plasminogen activator |
| U.K. | Urokinase |
| u-PA | Urokinase PA |
| urokinase | <enzyme> Serine protease from kidney that is a plasminogen activator. Contains EGF like domain. (18 Nov 1997) |
|---|---|
| urokinase-converting protease | <enzyme> Degrades synthetic urokinase substrates and stimulates urokinase Registry number: EC 3.4.21.- Synonym: urokinase cofactor (26 Jun 1999) |
| M23 urokinase | <chemical> A bifunctional molecule with fibrinolytic and thrombin-inhibitory activities; comprised of the protease domain and kringle structure of saruplase and the c-terminal part of hirudin Pharmacological action: fibrinolytic agents, antithrombins Synonym: urokinase m23, rscu-pa-40 kda-hir (26 Jun 1999) |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|---|---|---|---|
|
À¯·ÎŰ³ªÁ¦100,000´ÜÀ§ - »õâ
|
³ì½ÊÀÚ |
A10201101 | Urokinase | Àü¹®ÀǾàǰ | »èÁ¦ |
|
À¯ÇÑÀ¯·ÎŰ³ªÁ¦ÁÖ250,000´ÜÀ§ - »õâ
|
À¯ÇѾçÇà |
A04504961 | Urokinase | Àü¹®ÀǾàǰ | »èÁ¦ |
|
À¯·ÎƾÁÖ25¸¸IU - »õâ
|
Çѱ¹À¯³ªÀÌÆ¼µåÁ¦¾à |
A12941511 | Urokinase | Àü¹®ÀǾàǰ | ±Þ¿© |
|
À¯·ÎŰ³ªÁ¦ÁÖ20,000´ÜÀ§ - »õâ
|
³ì½ÊÀÚ |
A10201011 | Urokinase | Àü¹®ÀǾàǰ | »èÁ¦ |
|
¾¾Á¦ÀÌÀ¯·ÎŰ³ªÁ¦20,000¾ÆÀÌÀ¯ - »õâ
|
¾¾Á¦ÀÌ |
A11601341 | Urokinase | Àü¹®ÀǾàǰ | »èÁ¦ |
|
À¯ÇÑÀ¯·ÎŰ³ªÁ¦ÁÖ500,000´ÜÀ§ - »õâ
|
À¯ÇѾçÇà |
A04504971 | Urokinase | Àü¹®ÀǾàǰ | ±Þ¿© |
|
¾¾Á¦ÀÌÀ¯·ÎŰ³ªÁ¦ÁÖ100,000´ÜÀ§ - »õâ
|
¾¾Á¦ÀÌ |
A11601271 | Urokinase | Àü¹®ÀǾàǰ | »èÁ¦ |
|
¾¾Á¦ÀÌÀ¯·ÎŰ³ªÁ¦250,000¾ÆÀÌÀ¯ - »õâ
|
¾¾Á¦ÀÌ |
A11601551 | Urokinase | Àü¹®ÀǾàǰ | »èÁ¦ |
|
½ÅdzÀ¯·ÎŰ³ªÁ¦ÁÖ500,000´ÜÀ§ - »õâ
|
½ÅdzÁ¦¾à |
A00351061 | Urokinase | Àü¹®ÀǾàǰ | »èÁ¦ |
|
À¯¿µÀ¯·ÎŰ³ªÁ¦ÁÖ50,000´ÜÀ§ - »õâ
|
À¯¿µÁ¦¾à |
A34002271 | Urokinase | Àü¹®ÀǾàǰ | »èÁ¦ |
| urokinase |
plasminogen activator: protease produced in the kidney that converts plasminogen to plasmin and so initiates fibrinolysis
Ãâó: wordnet.princeton.edu/perl/webwn
|
|---|---|
| urokinase |
A drug that dissolves blood clots or prevents them from forming.
Ãâó: www.stjude.org/glossary
|
| urokinase-type plasminogen activator |
ABBR: uPA. A protein that degrades extracellular tissues. It has been linked to the spread of some cancers by invasion and metastasis.
Ãâó:
|
| Urokinase | protease produced in the kidney that converts plasminogen to plasmin and so initiates fibrinolysis |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|